INTRODUCTION
6 at this later time-point at all concentrations of fluconazole tested. We then selected for further 116 study any mutant that exhibited a reduction in MFC in both screens. Independent mutants were 117 constructed for these transcription factor genes or interest in the SC5314 background. lysates were clarified by centrifugation. The supernatant was then divided into two new 2-ml 162 microcentrifuge tubes each containing 950 µl of chloroform and mixed. The sample was then 163 subjected to centrifugation again, and the top aqueous layer was transferred to a new tube 164 containing 1 ml of isopropanol and 100 µl 2M sodium acetate. The RNA pellet was 165 subsequently washed with 500 µl of 70% ethanol and collected by centrifugation. The RNA was 166 then suspended in DNase/RNase-free H 2 O. Quantity and purity were determined 167 spectrophotometrically at absorbances of A 260 and A 280 . 168
169
Quantitative RT-PCR. First-strand cDNAs were synthesized from 1 µg of total RNA using 170
SuperScript first-strand synthesis system for qRT-PCR (Invitrogen). Gene-specific primers 171 (Table S2) were designed using Primer Express software (Applied Biosystems) and synthesized 172 by Integrated DNA Technologies (Coralville, IA). Quantitative PCRs were performed in 173 triplicate using the 7000 sequence detection system (Applied Biosystems), independently 174 amplifying ACT1 (normalizing gene) and the genes of interest as described previously (30). To 175 assess the statistical significance the Student t-test was performed using the significance level of 176 0.05. 177 178 RNA isolation for microarray. RNA was isolated using a large-scale version of the hot phenol 179 method of RNA isolation described by Schmitt et al. (29) . Briefly, overnight cultures were 180 diluted to an OD 600 of 0.005 in 100 ml YPD and then incubated at 30 cRNAs generated from C. albicans total RNA onto Affymetrix C. albicans custom expression 197 arrays (CAN07; 49-5241) (31), which have been described previously (32). Microarray 198 hybridization and analysis were performed as described previously (32). Genes were considered 199 to be differentially expressed in response to drug if their expression changed by ≥1.5-fold in two 200 independent experiments. Genes induced by fluconazole were considered to be CAS5-dependent 201 if the induction was abrogated in the deletion mutant was ≥2.0-fold (50%) less than the wild-202 type. All microarray data are available for download from the NCBI at the Gene Expression 203
Omnibus website: http://www.ncbi.nlm.nih.gov/geo/ (Accession number: GSE57930). 204
205

RESULTS
206
Disruption of Cas5 enhances fluconazole killing activity against C. albicans. In order to 208 identify transcriptional activation programs that influence the killing activity of the azole 209 antifungals against C. albicans, we first screened a collection of TF deletion mutants for those 210 that displayed an increase in fluconazole susceptibility as measured by broth microdilution in 211 RPMI medium (15). In order to detect marked reductions in MIC, a lower range of fluconazole 212 concentrations from 0.007 to 4 μg/ml was used, and 19 TFs from the library were identified with 213 reductions in fluconazole MIC at 48 hours in RPMI medium. These hits were then rescreened 214 for those that also displayed a reduction in fluconazole MFC in both RPMI (48 hours) and YPD 215 (24 hours) media (Table S3 ). We identified four TF mutants that met the criteria: CAS5, RPN4, 216 UPC2 and CZF1 (Table 1 ). The observation that disruption of UPC2 increased susceptibility to 217 fluconazole was not surprising as this has been reported previously (21, 33, 34), validating the 218 results of our screen. The remaining three TF deletion mutants which exhibited a reduction in 219 MFC in both RPMI and YPD were prioritized as being of greatest interest and independent 220 mutants were generated in the SC5314 background (Table 2 ). In order to determine the extent to 221 which disruption of these TF genes impacts the killing activity of fluconazole, the deletion 222 mutants were subjected to various susceptibility tests using the nutrient rich YPD media in order 223 to detect strong phenotypes despite existing in an environment that promotes growth. 224 225 CAS5 and RPN4 disruption had a moderate impact on fluconazole MIC, and a marked impact on 226 MFC by broth microdilution (Table 2) , and Etest ( Figure 1A ), while disruption of CZF1 had no 227 impact by all methods (data not shown). It should be noted that the disruption of CAS5 resulted 228 in slightly slower growth which may explain the subtle changes in fluconazole susceptibility that 229 were observed. The fluconazole MFC at 24 hours in YPD for SC5314 was >64 μg/ml whereas 230 the cas5Δ/Δ, rpn4Δ/Δ, and czf1Δ/Δ mutants were 1, 8, and >64 μg/ml respectively (Table 2) 
UPC2
G648D cas5Δ/Δ mutant cells to be larger than those of the parent strain and also to be 284 elongated and clumped together. As a result, susceptibility testing by both broth microdilution 285
and Etest for this strain was inconsistent due to the extreme variability in optical density versus 286 cell density, and therefore could not be reported. The disruption of CAS5 in each remaining 287 background did not markedly impact the MICs at 24 hours, but did result in a reduction in MIC 288 at later time points by all methods. The MFCs at 48 hours in YPD for ERG11 K143R cas52Δ/Δ, 289
MRR1
P683S cas5Δ/Δ and TAC1 G980E cas5Δ/Δ were all reduced from 8 μg/ml, >64 μg/ml, and >64 290 μg/ml in their background strains to 4 μg/ml, 8 μg/ml, and 16 μg/ml respectively ( 
TAC1
G980E cas5Δ/Δ were all reduced from 1.5 μg/ml, 6 μg/ml, and 8 μg/ml in their background 293 strains to 0.5 μg/ml, 1.5 μg/ml, and 6 μg/ml respectively ( Figure 3A disruption of CAS5 increased CDR2 expression in all backgrounds except for TAC1 G980E and 307
MRR1
P683S . Likewise, MDR1 expression also increased with the disruption of TAC1 in the 308 SC5314 and TAC1 G980E backgrounds. The significance of the increased expression of these 309 transporter genes is unclear. These data suggest that the enhanced killing activity of fluconazole 310 observed in resistant strains lacking CAS5 is not due to decreased levels of transporter gene 311 expression. Instead, the observed phenotypes may be associated with a reduction in ERG gene 312 expression, particularly ERG11. 313
314
Comparison of the gene expression profiles of wild-type strain SC5314 and cas5Δ/Δ 315 exposed to fluconazole. In order to identify genes whose expression in response to fluconazole 316 is influenced by Cas5, we compared the transcriptional profiles of SC5314 and its cas5Δ/Δ 317 derivative after treatment with or without 10 μg/ml fluconazole for six hours. Genes were 318 considered to be differentially-expressed in response to fluconazole if their expression changed 319 by ≥1.5-fold in two independent experiments (Dataset 1). Fluconazole-inducible genes were also 320 considered to be CAS5-dependent if their induction was abrogated in the deletion mutant and was 321 ≥2.0-fold (50%) less than compared to SC5314. Using these criteria, there were 209 genes 322 on June 21, 2017 by guest http://aac.asm.org/ Downloaded from upregulated by fluconazole whose induction was abrogated in the absence of CAS5 (Table 5) . 323
The most common biological processes represented by these genes include transport, response to 324 chemical stimulus, oxidation-reduction process, filamentous growth, lipid metabolic process and 325 cell wall organization. Interestingly, there were also six genes involved in iron ion transport, 326 binding, and homeostasis (CFL2, CFL4, FET34, FRE10, FTR1, orf19.1411) . genes have yet to be identified for many of these processes (7-14). In the present study, we 346 screened a library of C. albicans mutants disrupted for genes encoding TFs in order to identify 347 those which resulted in increased killing activity of fluconazole. We observed that disruption of 348 
